Laila al-Shaar
Global Medical Director in Medical Evidence Generation at Sanofi, Rare Diseases Launch and Pipeline
- Role
- Global Medical Director in Medical Evidence Generation, Rare Diseases Launch and Pipeline at Sanofi
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Laila al-Shaar
Global Medical Director leading integrated evidence-generation strategies across rare-disease pipeline and launch assets. Drives alignment and strategic partnerships across Medical Affairs, R&D, HEOR, Regulatory, Market Access, and Commercial teams to deliver decision-enabling evidence for regulators, payers, and clinicians. Applies deep expertise in epidemiology and real-world evidence, supported by 15+ year-experience and 65+ peer-reviewed publications, to translate complex data into launch-ready, impact-driven strategies that advance programs and improve outcomes for patients with rare diseases.
Experience
Global Medical Director in Medical Evidence Generation, Rare Diseases Launch and Pipeline
Jan 2025 — Present · Cambridge, MA, US
Education
American University of Beirut
MS, Biochemistry
2004 — 2006
Harvard University
PhD, Population Health Sciences
2016 — 2019
American University of Beirut
MPH, Public Health-Biostatistics and Epidemiology
2008 — 2010
Skills
- Teaching
- Epidemiology
- Biostatistics
- Molecular Biology
- Program Evaluation
- Public Health
- Medical Education
- Laboratory
- Statistics
- Data Analysis
- Healthcare
- Research
- Clinical Research
- Spss
- Literature Reviews
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.